Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Referral Guidelines for Imaging Exams: Impact on Exam Relevance and Associated Delays

NCT01785368
completed

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)

NCT00416741
completed

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

NCT00416611

Clinical Trials (3)

Showing 3 of 3 trials
NCT01785368Not Applicable

Referral Guidelines for Imaging Exams: Impact on Exam Relevance and Associated Delays

Completed
NCT00416741

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)

Completed
NCT00416611

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3